Search

everythinglearnresearchcommunity

for

Search:↓

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

Finasteride blocks progesterone's effect on absence seizures in rats.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

The nano-carrier makes etoposide safer and more effective against lung cancer.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Finasteride effectively reduces symptoms of male chronic pelvic pain syndrome with few side effects.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.